Confirmatory Study Nepafenac 0.3%
NCT01109173
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2120
Enrollment
INDUSTRY
Sponsor class
Conditions
Cataract
Interventions
DRUG:
Nepafenac Ophthalmic Suspension, 0.3%
DRUG:
Nepafenac Ophthalmic Suspension, 0.1%
OTHER:
Nepafenac Ophthalmic Suspension 0.3% Vehicle
OTHER:
NEVANAC Vehicle
Sponsor
Alcon Research